- Home
- BRAG vs ATRA Comparison
BRAG vs ATRA Comparison
Compare BRAG & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- ATRA
- Stock Information
- Founded
- BRAG 2018
- ATRA 2012
- Country
- BRAG Canada
- ATRA United States
- Employees
- BRAG N/A
- ATRA N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRAG Technology
- ATRA Health Care
- Exchange
- BRAG Nasdaq
- ATRA Nasdaq
- Market Cap
- BRAG 74.8M
- ATRA 67.9M
- IPO Year
- BRAG N/A
- ATRA 2014
- Fundamental
- Price
- BRAG $2.79
- ATRA $12.07
- Analyst Decision
- BRAG Buy
- ATRA Strong Buy
- Analyst Count
- BRAG 4
- ATRA 3
- Target Price
- BRAG $7.00
- ATRA $21.00
- AVG Volume (30 Days)
- BRAG 52.0K
- ATRA 44.8K
- Earning Date
- BRAG 11-13-2025
- ATRA 11-11-2025
- Dividend Yield
- BRAG N/A
- ATRA N/A
- EPS Growth
- BRAG N/A
- ATRA N/A
- EPS
- BRAG N/A
- ATRA 0.56
- Revenue
- BRAG $123,209,630.00
- ATRA $188,667,000.00
- Revenue This Year
- BRAG $6.62
- ATRA N/A
- Revenue Next Year
- BRAG $5.85
- ATRA N/A
- P/E Ratio
- BRAG N/A
- ATRA $21.29
- Revenue Growth
- BRAG 10.90
- ATRA 202.41
- 52 Week Low
- BRAG $2.59
- ATRA $5.01
- 52 Week High
- BRAG $6.12
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- BRAG 39.68
- ATRA 52.51
- Support Level
- BRAG $2.60
- ATRA $11.70
- Resistance Level
- BRAG $2.99
- ATRA $12.50
- Average True Range (ATR)
- BRAG 0.12
- ATRA 0.58
- MACD
- BRAG 0.08
- ATRA -0.12
- Stochastic Oscillator
- BRAG 50.38
- ATRA 39.46
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).